W 2022

FAME (Feasibility, Appropriateness, Meaningfulness, Effectiveness) of an Evidence Based Research approach in guideline production: Interactive workshop

KLUGAR, Miloslav, Klara BRUNNHUBER, Jitka KLUGAROVÁ, Karen ROBINSON, Jennifer YOST et. al.

Základní údaje

Originální název

FAME (Feasibility, Appropriateness, Meaningfulness, Effectiveness) of an Evidence Based Research approach in guideline production: Interactive workshop

Autoři

KLUGAR, Miloslav (203 Česká republika, domácí), Klara BRUNNHUBER, Jitka KLUGAROVÁ (203 Česká republika, domácí), Karen ROBINSON, Jennifer YOST a Hans LUND

Vydání

2022

Další údaje

Jazyk

angličtina

Typ výsledku

Uspořádání workshopu

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Kanada

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Kód RIV

RIV/00216224:14110/22:00126835

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Evidence-Based Research;

Štítky

Změněno: 10. 10. 2022 08:54, Mgr. Bc. Alena Langaufová, Ph.D.

Anotace

V originále

Background Evidence-Based Research (EBR) is a systematic and transparent approach needed to prevent research waste. It includes the whole research process from study concept and design through to placing new results in the context of earlier similar studies. The overall aim of EBR is to encourage researchers and other stakeholders to advocate for and use an EBR approach while carrying out and supporting clinical research – thus avoiding redundant research. Objective The aim of this workshop is to interactively explore with our attendees the Feasibility, Appropriateness, Meaningfulness, and Effectiveness (FAME) of EBR approach within the guideline community. Through the interactive discussion, participants will learn about and discuss the application of an EBR approach to guideline development to reduce research waste from primary and secondary research.

Návaznosti

LTC20031, projekt VaV
Název: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic, INTER-COST